QatarEnergy and ExxonMobil Sign Deal to Export Cypriot Gas to Europe via Egypt QXO Launches Hostile Takeover Bid for BuildingProducts Rival Beacon Crossroads Capitals Investment Thesis for Nebius Group NBIS Shows Positive Results Applied Digital APLD Surges to AllTime High as AI Lease Revenues Reach 73 Billion Strait of Hormuz Closure Could Drive Oil to New Highs in Summer Piper Sandler Suggests US Monthly Retail Sales Report Points to Moderate Consumer Spending Growth STAA Q1 2026 Earnings EPS Soars Past Estimates Stock Declines Despite Strong Beat SCCG Q4 2025 Earnings Significant EPS Beat Despite Stock Decline Victory Capital Holdings Inc VCTR Q1 2026 Earnings EPS Tops Estimates as Asset Manager Delivers Solid Profit Performance Quaker Houghton KWR Q1 2026 Earnings Narrow EPS Miss Fails to Dampen Investor Sentiment as Stock Rises PAVmed Q1 2026 Earnings WiderthanExpected Loss as Revenue Remains Absent OppFi Inc Q1 2026 Earnings EPS Surpasses Estimates Amidst Solid Operational Performance ConnectOne Bancorp Preferred CNOBP Edges Higher as Yield Seeks Support CocaCola Consolidated COKE Slightly Lower at 17646 Consolidation Continues Venu Holding Corporation VENU Holds Near Key Support Amid Modest Gains American Rebel Holdings AREB Surges 26 as Penny Stock Finds New Buying Interest at 006 Guidewire Software GWRE Retreats Slightly Testing Support After Mixed Session Consumer Credit Growth Surges in December Signaling Robust Holiday Spending ASP Isotopes Q4 2025 Earnings PreRevenue Developer Reports WiderthanExpected Loss Yet Shares Rally 735 Western Digital WDC Surges 834 Momentum Building Toward Key Resistance Tillys Inc TLYS Faces Selling Pressure Near Key Support Level Reliance Global Group EZRA Shares Dip 25 as Stock Tests Key Support Hershey HSY Rallies Over 4 Approaches Resistance After Finding Support Blackstone Strategic Credit 2027 Term Fund BGB Holds Steady at 1134 as Market Waits for Catalysts LSI Industries Inc LYTS Slides 170 as Stock Approaches Key Support Zone Elevra Lithium ELVR Slides 668 as Selling Pressure Intensifies Aclaris Therapeutics ACRS Gains 244 as Buyers Defend Key Support Zone